GATA2 Deficiency
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
|
Disease or Syndrome
|
9
|
18
|
0.800 |
definitive |
1.000 |
34 |
18
|
1994 |
2019 |
Emberger Syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
|
Disease or Syndrome
|
2
|
15
|
0.770 |
None |
1.000 |
21 |
15
|
2010 |
2018 |
LEUKEMIA, ACUTE MYELOID, SUSCEPTIBILITY TO
|
phenotype |
|
Finding
|
1
|
7
|
0.100 |
None |
|
0 |
6
|
|
|
Leukemia, Myelocytic, Acute
|
disease |
Neoplasms
|
Neoplastic Process
|
3111
|
6892
|
0.800 |
None |
0.974 |
39 |
2
|
1994 |
2020 |
Coronary Artery Disease
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
1708
|
1577
|
0.070 |
None |
0.857 |
7 |
2
|
2006 |
2017 |
MYELODYSPLASTIC SYNDROME
|
group |
Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1033
|
95
|
0.800 |
None |
0.976 |
42 |
1
|
2002 |
2019 |
Monosomy
|
group |
Pathological Conditions, Signs and Symptoms
|
Congenital Abnormality
|
214
|
11
|
0.050 |
None |
1.000 |
5 |
1
|
2012 |
2017 |
Myeloid Leukemia, Chronic
|
disease |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1172
|
115
|
0.050 |
None |
1.000 |
5 |
1
|
1995 |
2014 |
Hematologic Neoplasms
|
group |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
827
|
60
|
0.040 |
None |
1.000 |
4 |
1
|
2009 |
2019 |
Colorectal Carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
5473
|
1962
|
0.040 |
None |
0.750 |
4 |
1
|
2013 |
2016 |
Malignant neoplasm of colon and/or rectum
|
disease |
|
Neoplastic Process
|
3669
|
502
|
0.040 |
None |
0.750 |
4 |
1
|
2013 |
2016 |
Eosinophilia
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
325
|
23
|
0.020 |
None |
1.000 |
2 |
1
|
2008 |
2010 |
Blast Phase
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
299
|
14
|
0.020 |
None |
1.000 |
2 |
1
|
2008 |
2008 |
Eosinophilic disorder
|
group |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
288
|
22
|
0.020 |
None |
1.000 |
2 |
1
|
2008 |
2010 |
Obesity
|
disease |
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
2821
|
1111
|
0.010 |
None |
1.000 |
1 |
1
|
2015 |
2015 |
CML progression
|
disease |
|
Neoplastic Process
|
47
|
3
|
0.010 |
None |
1.000 |
1 |
1
|
2009 |
2009 |
Diastolic blood pressure
|
phenotype |
|
Clinical Attribute
|
507
|
1037
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Systolic Pressure
|
phenotype |
|
Clinical Attribute
|
843
|
1931
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.100 |
None |
0.952 |
21 |
|
2011 |
2020 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.100 |
None |
1.000 |
17 |
|
2012 |
2020 |
Childhood Myelodysplastic Syndrome
|
disease |
Hemic and Lymphatic Diseases
|
Neoplastic Process
|
335
|
20
|
0.100 |
None |
1.000 |
14 |
|
2011 |
2019 |
Adult Myelodysplastic Syndrome
|
disease |
Hemic and Lymphatic Diseases
|
Neoplastic Process
|
332
|
20
|
0.100 |
None |
1.000 |
13 |
|
2011 |
2019 |
Malignant neoplasm of prostate
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4502
|
1082
|
0.100 |
None |
1.000 |
12 |
|
2009 |
2019 |
Prostate carcinoma
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4388
|
1168
|
0.100 |
None |
1.000 |
12 |
|
2009 |
2019 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.100 |
None |
1.000 |
11 |
|
2012 |
2018 |